Shanghai, China - On December 8, 2017, Waters Corporation recently held a two-day 'High-Definition Mass Spectrometry - Biopharmaceutical User' Training Course in Beijing, Shanghai and Guangzhou, attracting over 100 participants from Bio-pharmaceutical companies, drug testing agencies, third-party inspection agencies, CRO companies and research institutes and other units to participate in. During the training course, many Waters application and after-sales experts for biological products routine analysis and inspection encountered in the high Identify the use of mass spectrometry, for the participants a professional and detailed answers.
Historically, biopharmaceuticals have placed high demands on the performance and stability of analytical instruments, and at the same time, researchers have sought to devote more time to data interpretation by saving on the time spent on instrumentation and data processing. Discriminant mass spectrometry has obvious advantages in the analysis of complex structures, monitoring of multiple quality attributes, spectrum quality and stability, and therefore plays an important role in the development and quality assurance system of biopharmaceuticals. As a high resolution mass spectrometer for biopharmaceuticals, A leader in solutions, Waters held this training course to share its wealth of experience in the biopharmaceutical industry and to target the implementation of a platform for biopharmaceutical solutions based on the UNIFI Scientific Data Management System, Systematic training.
Waters 'High Definition Mass Spectrometry - Biopharmaceutical User Project' Beijing Training Course
Waters 'High Resolution Mass Spectrometry - Biopharmaceutical User Project' Shanghai Training Course
Waters 'High Resolution Mass Spectrometry - Biopharmaceutical User Project' Guangzhou Training Course
This training course is informative and informative. Senior application experts from all regions of Waters around the biopharmaceutical R & D cycle have conducted in-depth testing programs and analyzed and analyzed the complete protein analysis, peptide map Analysis, free N-glycan analysis of many specific issues, including monoclonal antibody molecular weight determination, ADCs drug DAR value, conventional peptide mapping analysis, disulfide bond analysis, UNIFI screening function for post-translational modification of the proportion of monitoring, before the sample Treatment, qualitative and quantitative analysis of free N-glycan, quality control of process, etc. Subsequently, after-sale experts in Waters high resolution mass spectrometry shared the precautions and maintenance of the UPLC-QTof system, and the dry and dry courses were actively discussed by the on- Warm praise.
At the scene, trainees also conducted UNIFI software operation on the machine under the guidance of Waters engineers and learned methods of setting up, data collection, data analysis and compliance reporting, and got a deeper understanding of the use of the software An analyst from a leading biopharmaceutical company said: "Our company was one of the older users of Waters High Definition Mass Spectrometry and we have multiple drugs based on BiopharmaLynx software coming into the approval phase, and several of them have taken To the clinical approval, a drug has already got the production approval. The continuous support of Waters engineers over the years has enabled our entire analysis platform to run smoothly and the needs of various departments in sample analysis and characterization are guaranteed. After the UNIFI system was newly upgraded, Compliance and reporting are even better, and we will continue to participate in compliance-related training to cope more easily with the CFDA's review. "
Dr. Chen Xi, Senior Applications Specialist, Waters Asia Pacific Region (left) and Han Zhiguo, Senior Applications Engineer, Waters North Region (right)
Instruct students to operate on the machine
Ms. Song Lankun, senior manager of Waters Pharmaceutical Market, said: "With the development of the biopharmaceutical industry, more and more research hot spots are emerging. High-resolution mass spectrometry plays an irreplaceable role in the development and quality control of biopharmaceuticals. This series of training sessions for the biopharmaceutical industry is aimed at giving our practitioners more in-depth and comprehensive knowledge of the application, operation and maintenance of high-resolution mass spectrometry while enhancing their practical abilities and providing them to everyone Provides a platform for sharing tips and experience with high-resolution mass spectrometry. '
About UNIFI Biopharmaceutical Platform
The Waters UNIFI Biopharmaceutical Platform combines robust UPLC / MS characterization with powerful software for bioseparations, complete protein profiling, peptide mapping, and glycoside analysis. The UNIFI-based Waters Biopharmaceutical System The solution enables biopharmaceutical laboratories to collect and process comprehensive LC / MS analysis data while sharing data throughout the biopharmaceutical product lifecycle, covering all aspects of biopharmaceutical analysis and standardized analytical workflows. Analytical laboratories make it easy to get reliable results and share data between research and development and GxP QC labs.